166 related articles for article (PubMed ID: 33729740)
21. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
Zhang HZ; Dong L; Wang SY; Yang XQ
Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
[TBL] [Abstract][Full Text] [Related]
22. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
[TBL] [Abstract][Full Text] [Related]
23. Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.
Shah AA; Ohori NP; Yip L; Coyne C; Antonescu CR; Seethala RR
Endocr Pathol; 2016 Jun; 27(2):147-52. PubMed ID: 27026033
[TBL] [Abstract][Full Text] [Related]
24. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases.
Deyrup AT; Tighiouart M; Montag AG; Weiss SW
Am J Surg Pathol; 2008 Jun; 32(6):924-7. PubMed ID: 18551749
[TBL] [Abstract][Full Text] [Related]
25. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
26. Proposed diagnostic and prognostic markers of primary malignant hepatic vascular neoplasms.
Yoo Y; Shin J; Jun E; Koh EY; Shin HJ; Kang HJ
Diagn Pathol; 2024 May; 19(1):68. PubMed ID: 38741104
[TBL] [Abstract][Full Text] [Related]
27. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
[TBL] [Abstract][Full Text] [Related]
28.
Seavey CN; Pobbati AV; Hallett A; Ma S; Reynolds JP; Kanai R; Lamar JM; Rubin BP
Genes Dev; 2021 Apr; 35(7-8):512-527. PubMed ID: 33766982
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of hepatic epithelioid hemangioendothelioma reveals alterations in various genes involved in DNA repair, epigenetic regulation, signaling pathways, and cell cycle control.
Mogler C; Koschny R; Heilig CE; Frohling S; Schirmacher P; Weichert W; Pfarr N
Genes Chromosomes Cancer; 2020 Feb; 59(2):106-110. PubMed ID: 31390105
[TBL] [Abstract][Full Text] [Related]
30. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant.
Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T
Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
32. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.
Errani C; Zhang L; Panicek DM; Healey JH; Antonescu CR
Clin Orthop Relat Res; 2012 May; 470(5):1498-506. PubMed ID: 21948309
[TBL] [Abstract][Full Text] [Related]
33. Malignant vascular tumors--an update.
Antonescu C
Mod Pathol; 2014 Jan; 27 Suppl 1():S30-8. PubMed ID: 24384851
[TBL] [Abstract][Full Text] [Related]
34. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
35. Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.
Perry KD; Al-Lbraheemi A; Rubin BP; Jen J; Ren H; Jang JS; Nair A; Davila J; Pambuccian S; Horvai A; Sukov W; Tazelaar HD; Folpe AL
Mod Pathol; 2017 Nov; 30(11):1589-1602. PubMed ID: 28731049
[TBL] [Abstract][Full Text] [Related]
36. [Epithelioid hemangioendothelioma of the lung (IVBAT)--clinicopathological and immunohistochemical analysis of 11 cases].
Einsfelder B; Kuhnen C
Pathologe; 2006 Mar; 27(2):106-15. PubMed ID: 16421704
[TBL] [Abstract][Full Text] [Related]
37. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer.
Lau K; Massad M; Pollak C; Rubin C; Yeh J; Wang J; Edelman G; Yeh J; Prasad S; Weinberg G
Chest; 2011 Nov; 140(5):1312-1318. PubMed ID: 21546438
[TBL] [Abstract][Full Text] [Related]
38. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
39. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
Brimo F; Robinson B; Guo C; Zhou M; Latour M; Epstein JI
Am J Surg Pathol; 2010 May; 34(5):715-22. PubMed ID: 20410812
[TBL] [Abstract][Full Text] [Related]
40. Malignant pleuropulmonary epithelioid hemangioendothelioma - unusual presentation of an aggressive angiogenic neoplasm.
Mucientes P; Gomez-Arellano L; Rao N
Pathol Res Pract; 2014 Sep; 210(9):613-8. PubMed ID: 24939148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
